Ann Hayes

Ann Hayes is a prominent figure in the pharmaceutical and biotechnology industry with extensive experience in drug discovery and development. She is the owner of The Ann Hayes Consultancy, where she provides consulting services to pharmaceutical and biotechnology companies, as well as venture capitalists.2

Professional Background

Dr. Ann Hayes has had a distinguished career in pharmacology and drug discovery. She previously worked at Glaxo (now part of GSK), where she likely played a significant role during a period of technological revolution in the field.1 Her expertise spans various areas of drug discovery, from research through development stages.2

Current Role and Services

As the owner of The Ann Hayes Consultancy, Dr. Hayes offers her expertise in:

• Portfolio management
• Digital health
• Drug discovery and development processes

She assists companies in the pharmaceutical and biotechnology sectors, leveraging her vast experience to provide valuable insights and guidance.

Achievements and Recognition

Dr. Hayes has been recognized for her contributions to the field of pharmacology:

• She is an Honorary Fellow of the British Pharmacological Society.1
• She has been appointed to chair a joint steering committee for ELRIG UK and the British Pharmacological Society, highlighting her leadership in the industry.3

Areas of Expertise

Throughout her career, Dr. Hayes has developed expertise in:

• Pharmacology
• Drug discovery and development
• Portfolio management
• Digital health applications in pharma
• Consulting for biotech and pharmaceutical companies

Dr. Ann Hayes continues to be an influential figure in the pharmaceutical industry, offering her wealth of knowledge and experience through her consultancy to drive innovation and progress in drug discovery and development.